Ignite Creation Date:
2025-12-24 @ 2:51 PM
Ignite Modification Date:
2025-12-26 @ 6:06 AM
Study NCT ID:
NCT03379259
Status:
TERMINATED
Last Update Posted:
2024-10-26
First Post:
2017-12-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of BGB-A333 Alone and in Combination With Tislelizumab in Advanced Solid Tumors
Sponsor:
BeiGene
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-27
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-08
Completion Date Type:
ACTUAL
First Submit Date:
2017-12-11
First Submit QC Date:
None
Study First Post Date:
2017-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-09-03
Results First Submit QC Date:
None
Results First Post Date:
2021-11-09
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-23
Last Update Post Date:
2024-10-26
Last Update Post Date Type:
ACTUAL